Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
072020.KQ
BUYREMOVEChoong Ang Vaccine Laboratory Co., Ltd. · Healthcare · South Korea · $57M · Avg Vol: $140K/d
Choong Ang Vaccine Laboratory is a niche animal vaccine manufacturer. It lacks the scale, pricing power, and global distribution network required to meet our quality compounder threshold.
COMPANY DESCRIPTION
Choong Ang Vaccine Laboratory Co., Ltd. develops, manufactures, and distributes veterinary vaccines and biopharmaceuticals for livestock, poultry, and companion animals. The company's competitive advantage lies in its extensive portfolio of proprietary vaccines tailored to regional animal diseases and its strong domestic distribution network. It is a leading animal health player in South Korea, increasingly targeting export markets in Southeast Asia.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 25.6M | 27.3M | 29.7M | 32.0M | 7.7% |
| EPS | 0.27 | 0.40 | 0.46 | 0.43 | 16.5% |
| Shares | 10.0M | 9.7M | 9.7M | 9.4M | -6.1% |
| Debt | 8.2M | 7.2M | 5.8M | 4.6M | -17.4% |
| Equity | 62.1M | 65.0M | 67.6M | 68.6M | 3.4% |
| Op CF | 4.6M | 8.3M | 8.7M | 5.1M | 3.6% |
| Inv CF | -6.0M | -2.2M | -6.5M | -2.9M | — |
| Fin CF | -1.0M | -1.8M | -3.1M | -4.2M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 072020.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 072020.KQ | Choong Ang Vaccine Laboratory Co., Ltd.(you) | $57M | 77 | BUY |
| 131030.KQ | DHP Korea Co., Ltd. | $62M | 72 | BUY |
| 002620.KS | Jeil Pharma Holdings Inc | $68M | 72 | BUY |
| 330350.KQ | WITHUS PHARMACEUTICAL Co.,LTD. | $73M | 66 | BUY |
| 054670.KQ | Daehan Nupharm Co.,Ltd. | $51M | 62 | HOLD |
| 008490.KS | Suheung Co., Ltd. | $132M | 79 | BUY |
| 106190.KQ | High Tech Pharm Co., Ltd. | $100M | 66 | BUY |
| 023910.KQ | Daihan Pharmaceutical Co.,Ltd. | $96M | 90 | STRONG BUY |
| 001540.KQ | Ahn-Gook Pharmaceutical Co., Ltd. | $74M | 99 | STRONG BUY |
| 293480.KS | Hana Pharm Co., Ltd. | $103M | 61 | HOLD |
Peer medians: ROE 0.1% · P/E 16.8x · Gross margin 43.8%